| 000 | na a22 4500 | ||
|---|---|---|---|
| 999 |
_c7922 _d7922 |
||
| 003 | PC7922 | ||
| 005 | 20190719140051.0 | ||
| 008 | 130622s2013 xxx||||| |||| 00| 0 eng d | ||
| 040 | _cH12O | ||
| 041 | _aeng | ||
| 100 |
_aCabeza Rodríguez, Mª Ángeles _9435 _eOncología Radioterápica |
||
| 245 |
_h[comunicación] _aLate Side Effects in Men With Intermediate- and High-RiskProstate Cancer Treated With High-Dose Radiation Therapy andAndrogen Deprivation (DART 01/05): Secondary Endpoints Froma Phase 3 Clinical Trial. |
||
| 260 |
_bInternational Journal of Radiation Oncology Biology Physics, _c2013 |
||
| 300 | _a87(2):S105. | ||
| 500 | _aFormato Vancouver: Zapatero A, Guerrero A, Maldonado X, Álvarez A, San Segundo CG, Cabeza M, et al. Late side effects in men with intermediate- and high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation (DART 01/05): Secondary endpoints from a phase 3 clinical trial. Int J Radiat Oncol Biol Phys. 2013;87(2):S105 [Annual Meeting of the American Society for Radiation Oncology (55. 2013. Atlanta, GA.)] | ||
| 710 |
_9302 _aServicio de Oncología Radioterápica |
||
| 856 |
_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/7/pc7922.pdf _ySolicitar documento |
||
| 942 |
_n0 _2ddc _cCOM |
||